Inhaled nitric oxide and hemodynamic evaluation of patients with pulmonary hypertension before transplantation

Department of Cardiology, Children's Hospital, Boston, Massachusetts 02115, USA.

OBJECTIVES. We investigated the effect of inhaled nitric oxide and infused acetylcholine in patients with pulmonary hypertension undergoing cardiac catheterization before cardiopulmonary transplantation. BACKGROUND. The fate of patients under consideration for transplantation of the heart or lungs, or both, is influenced by the evaluation of their pulmonary vascular reactivity. METHODS. We evaluated 11 patients who were classified into two groups on the basis of mean left atrial pressure > 15 mm Hg (group I, n = 6) or < or = 15 mm Hg (group II, n = 5). All patients inhaled nitric oxide at 80 ppm. This was preceded by an infusion of 10(-6) mol/liter of acetylcholine in seven consecutive patients (n = 3 in group I, n = 4 in group II). RESULTS. In group I, inhaled nitric oxide decreased pulmonary artery pressure from (mean +/- SE) 71 +/- 13 to 59 +/- 10 mm Hg (p < 0.05), pulmonary vascular resistance from 14.9 +/- 3.8 to 7.6 +/- 1.7 Um2 (p < 0.05) and intrapulmonary shunt fraction from 17.8 +/- 3.6% to 12.7 +/- 2.1% (p < 0.05). Left atrial pressure tended to increase from 27 +/- 4 to 32 +/- 5 mm Hg (p = 0.07). In group II pulmonary vascular resistance decreased in response to nitric oxide from 36.4 +/- 9.0 to 31.1 +/- 7.9 Um2 (p < 0.05). Cardiac index, systemic pressure and resistance did not change in either group. Seven patients who received acetylcholine had no significant alteration in pulmonary hemodynamic variables. CONCLUSIONS. These preliminary observations suggest that nitric oxide is a potent pulmonary vasodilator with minimal systemic effects. It may be useful in discriminating patients needing combined heart and lung transplantation from those requiring exchange of the heart alone.

This article has been cited by other articles:

				D. Matamis, S. Pampori, A. Papathanasiou, P. Papakonstantinou, M. Tsagourias, E. Galiatsou, V. Koulouras, and G. Nakos Inhaled NO and Sildenafil Combination in Cardiac Surgery Patients With Out-of-Proportion Pulmonary Hypertension: Acute Effects on Postoperative Gas Exchange and Hemodynamics Circ Heart Fail, January 1, 2012; 5(1): 47 - 53. [Abstract] [Full Text] [PDF]

				A. Pagnamenta, C. Dewachter, K. McEntee, P. Fesler, S. Brimioulle, and R. Naeije Early right ventriculo-arterial uncoupling in borderline pulmonary hypertension on experimental heart failure J Appl Physiol, October 1, 2010; 109(4): 1080 - 1085. [Abstract] [Full Text] [PDF]

				L. C. Price, D. Montani, X. Jais, J. R. Dick, G. Simonneau, O. Sitbon, F. J. Mercier, and M. Humbert Noncardiothoracic nonobstetric surgery in mild-to-moderate pulmonary hypertension Eur. Respir. J., June 1, 2010; 35(6): 1294 - 1302. [Abstract] [Full Text] [PDF]

				A. Hoskote, C. Carter, P. Rees, M. Elliott, M. Burch, and K. Brown Acute right ventricular failure after pediatric cardiac transplant: Predictors and long-term outcome in current era of transplantation medicine J. Thorac. Cardiovasc. Surg., January 1, 2010; 139(1): 146 - 153. [Abstract] [Full Text] [PDF]

				C. E. Canter, R. E. Shaddy, D. Bernstein, D. T. Hsu, M. R.K. Chrisant, J. K. Kirklin, K. R. Kanter, R. S.D. Higgins, E. D. Blume, D. N. Rosenthal, et al. Indications for Heart Transplantation in Pediatric Heart Disease: A Scientific Statement From the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group Circulation, February 6, 2007; 115(5): 658 - 676. [Abstract] [Full Text] [PDF]

				S. L. Merklinger, R. A. Wagner, E. Spiekerkoetter, A. Hinek, R. H. Knutsen, M. G. Kabir, K. Desai, S. Hacker, L. Wang, G. M. Cann, et al. Increased Fibulin-5 and Elastin in S100A4/Mts1 Mice With Pulmonary Hypertension Circ. Res., September 16, 2005; 97(6): 596 - 604. [Abstract] [Full Text] [PDF]

				D. N. Cornfield, E. R. Resnik, J. M. Herron, O. Reinhartz, and J. R. Fineman Pulmonary vascular K+ channel expression and vasoreactivity in a model of congenital heart disease Am J Physiol Lung Cell Mol Physiol, December 1, 2002; 283(6): L1210 - L1219. [Abstract] [Full Text] [PDF]

				E. Michelakis, W. Tymchak, D. Lien, L. Webster, K. Hashimoto, and S. Archer Oral Sildenafil Is an Effective and Specific Pulmonary Vasodilator in Patients With Pulmonary Arterial Hypertension: Comparison With Inhaled Nitric Oxide Circulation, May 21, 2002; 105(20): 2398 - 2403. [Abstract] [Full Text] [PDF]

				J. K. Kirklin Pediatric cardiac transplantation Ann. Thorac. Surg., May 1, 2000; 69(5): 1627 - 1628. [Full Text] [PDF]

				C. S Hayward, R. P Kelly, and P. S Macdonald Inhaled nitric oxide in cardiology practice Cardiovasc Res, August 15, 1999; 43(3): 628 - 638. [Abstract] [Full Text] [PDF]

				A. M. Atz, I. Adatia, J. E. Lock, and D. L. Wessel Combined effects of nitric oxide and oxygen during acute pulmonary vasodilator testing J. Am. Coll. Cardiol., March 1, 1999; 33(3): 813 - 819. [Abstract] [Full Text] [PDF]

				M I Turanlahti, P O Laitinen, S J Sarna, and E Pesonen Nitric oxide, oxygen, and prostacyclin in children with pulmonary hypertension Heart, February 1, 1998; 79(2): 169 - 174. [Abstract] [Full Text]

				E. P. Chen, H. B. Bittner, F. Tull, D. Craig, R. D. Davis, and P. Van Trigt NITRIC OXIDE IMPROVES PULMONARY VASCULAR IMPEDANCE, TRANSPULMONARY EFFICIENCY, AND LEFT VENTRICULAR FILLING IN CHRONIC PULMONARY HYPERTENSION J. Thorac. Cardiovasc. Surg., May 1, 1997; 113(5): 849 - 857. [Abstract] [Full Text]

				A. M. Atz, I. Adatia, and D. L. Wessel Rebound Pulmonary Hypertension After Inhalation of Nitric Oxide Ann. Thorac. Surg., December 1, 1996; 62(6): 1759 - 1764. [Abstract] [Full Text]

				D. A. Fullerton and R. C. McIntyre Jr Inhaled Nitric Oxide: Therapeutic Applications in Cardiothoracic Surgery Ann. Thorac. Surg., June 1, 1996; 61(6): 1856 - 1864. [Abstract] [Full Text]